Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstruct…
$0.09-8.67%
报价 2026-11-06
市值
$1.3M
EV
$12.5M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -96.4%
$0.09$2.59
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| VVOSVivos Therapeutics, Inc. | $1.3M | -8.7% | +12.6% | 59.7% | – | – | – | |
| ANLAdlai Nortye Ltd. | $545.7M | +6.2% | – | 100% | – | – | – | |
| COCHEnvoy Medical, Inc. | $55.3M | +0.7% | 0.0% | -310.7% | – | – | – | |
| LPCNLipocine Inc. | $12.9M | +2.6% | -33.3% | -8.2% | – | – | – | |
| AMSAmerican Shared Hospital Services | $7.7M | -0.9% | +2.1% | 18.5% | – | 6.4x | – | |
| NVNOenVVeno Medical Corporation | $4.7M | -3.4% | +59.1% | 0% | – | – | – | |
| AEMDAethlon Medical, Inc. | $2.9M | +3.0% | -100.0% | 0% | – | – | – | |
| ADGMAdagio Medical Holdings, Inc. | $1.8M | +6.4% | – | 0% | – | – | – | |
| 同行中位数 | – | – | 0.0% | 0% | – | 6.4x | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。